Opening book details…
About this book
In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020 by James A. Karlowsky & Sibylle H. Lob & C. Andrew DeRyke & David W. Hilbert & Michael T. Wong & Katherine Young & Fakhar Siddiqui & Mary R. Motyl & Daniel F. Sahm is a book available to read on EtoBox.
- Author
- James A. Karlowsky & Sibylle H. Lob & C. Andrew DeRyke & David W. Hilbert & Michael T. Wong & Katherine Young & Fakhar Siddiqui & Mary R. Motyl & Daniel F. Sahm
- Publisher
- American Society for Microbiology
- Published
- 2022
- Language
- EN
More by James A. Karlowsky & Sibylle H. Lob & C. Andrew DeRyke & David W. Hilbert & Michael T. Wong & Katherine Young & Fakhar Siddiqui & Mary R. Motyl & Daniel F. Sahm
Similar books
- Clinical Outcomes and Emergence of Resistance of Pseudomonas Aeruginosa Infections Treated with Ceftolozane-tazobactam Versus Ceftazidime-avibactam — Dariusz A. Hareza & Sara E. Cosgrove & Robert A. Bonomo & Kathryn Dzintars & Sara M. Karaba & Armani M. Hawes & Tsigereda Tekle & Patricia J. Simner & Pranita D. Tamma (2024)
- In Vitro Activity of Imipenem/relebactam Against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis — Victor H. Ruiz & Andrew Fratoni & David P. Nicolau & Joseph L. Kuti (2023)
- Mutant Prevention Concentrations, in Vitro Resistance Evolution Dynamics, and Mechanisms of Resistance to Imipenem and Imipenem/relebactam in Carbapenem-susceptible Klebsiella Pneumoniae Isolates Showing Ceftazidime/avibactam Resistance — Tania Blanco-Martín & Lucía González-Pinto & Pablo Aja-Macaya & Salud Rodríguez-Pallares & Lucía Sánchez-Peña & Eva Gato & María del Carmen Fernández-López & Michelle Outeda-García & Arianna Rodríguez-Coello & Rosa Pedraza-Merino & Isaac Alonso-García... (2024)
- Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections — Alba Ruedas-López & Isaac Alonso-García & Cristina Lasarte-Monterrubio & Paula Guijarro-Sánchez & Eva Gato & Juan Carlos Vázquez-Ucha & Juan Andrés Vallejo & Pablo Arturo Fraile-Ribot & Begoña Fernández-Pérez & David Velasco & José María... (2022)
- Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study — Thamer A. Almangour & Leen Ghonem & Dareen Alassiri & Alanoud Aljurbua & Mohammed Al Musawa & Aminah Alharbi & Abdullah Almohaizeie & Sara Almuhisen & Jeelan Alghaith & Nader Damfu & Doaa Aljefri & Wafa Alfahad & Yaqoub Khormi & Menyfah Q. Alanazi &... (2023)
- Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam — Naphat Satapoomin & Punyawee Dulyayangkul & Matthew B. Avison (2022)